jueves, 30 de abril de 2020

Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients | India News,The Indian Express

Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients | India News,The Indian Express

Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients



In a study in the medical journal The Lancet, Chinese researchers have reported that they could not find any “statistically significant clinical benefits”.

No hay comentarios: